Instruments to identify prescription medication misuse, abuse, and related events in clinical trials: An ACTTION systematic review

Journal of Pain

Volumn 16, Issue 5, 2015, Pages 389-411

  Smith, Shannon M ^a   Paillard, Florence ^b   McKeown, Andrew ^a   Burke, Laurie B ^c   Edwards, Robert R ^d   Katz, Nathaniel P ^e,f   Papadopoulos, Elektra J ^g   Rappaport, Bob A ^g   Slagle, Ashley ^g   Strain, Eric C ^h   Wasan, Ajay D ⁱ   Turk, Dennis C ^j   Dworkin, Robert H ^k  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b FocusBiocom   (United States)

^c PharmD Consulting   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e TUFTS UNIVERSITY   (United States)

^f Analgesic Solutions   (United States)

^g CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF WASHINGTON   (United States)

^k UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

more..

Author keywords

Abuse potential; Clinical trial; Measurement properties; Misuse

Indexed keywords

PRESCRIPTION DRUG;

ABUSE INDEX ALGORITHM; ADDICTION BEHAVIORS CHECKLIST; ADDICTION SEVERITY INDEX; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL (TOPIC); CONSTRUCT VALIDITY; CONTENT VALIDITY; CROSS-SECTIONAL STUDY; CURRENT OPIOID MISUSE MEASURE; DRUG ABUSE; DRUG ABUSE SCREENING TEST; DRUG MISUSE; DRUG MISUSE INDEX; EUROPEAN; HANSEN ABERRANT BEHAVIOR LIST; HUMAN; INAPPROPRIATE PRESCRIBING; JEEVANJEE OPIOID ANALGESIC MISUSE CHECKLIST; LIFESPAN; LONGITUDINAL STUDY; MANCHIKANTI SCREENING EVALUATION TOOL; OUTCOME ASSESSMENT; PAIN ASSESSMENT AND DOCUMENTATION TOOL; PRESCRIBED OPIOID DIFFICULTY SCALE CONCERN SCALE; PRESCRIPTION; PRESCRIPTION DRUG USE QUESTIONNAIRE; PRESCRIPTION OPIOID ABUSE CHECKLIST; PRESCRIPTION OPIOID MISUSE INDEX; PRESCRIPTION OPIOID THERAPY QUESTIONNAIRE; RELIABILITY; REVIEW; SYSTEMATIC REVIEW; UNITED STATES; PRACTICE GUIDELINE; PROCEDURES; QUESTIONNAIRE; STANDARDS;

CLINICAL TRIALS AS TOPIC; GUIDELINES AS TOPIC; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PRESCRIPTION DRUG MISUSE; SURVEYS AND QUESTIONNAIRES;

EID: 84928826743     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2015.01.009     Document Type: Review

References (63)

1. E.H. Adams, S. Breiner, T.J. Cicero, A. Geller, J.A. Inciardi, S.H. Schnoll, E.C. Senay, and G.E. Woody A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain J Pain Symptom Manage 31 2006 465 476
2. American Academy of Pain Medicine, American Pain Society, American Society of Addiction Medicine Definitions related to the use of opioids for the treatment of pain WMJ 100 2001 28 29
3. C.J. Banta-Green, J.O. Merrill, S.R. Doyle, D.M. Boudreau, and D.A. Calsyn Measurement of opioid problems among chronic pain patients in a general medical population Drug Alcohol Depend 104 2009 43 49
4. C.J. Banta-Green, M. Von Korff, M.D. Sullivan, J.O. Merrill, S.R. Doyle, and K. Saunders The prescribed opioids difficulties scale: A patient-centered assessment of problems and concerns Clin J Pain 26 2010 489 497
5. W.C. Becker, L. Fraenkel, E.J. Edelman, S.R. Holt, J. Glover, R.D. Kerns, and D.A. Fiellin Instruments to assess patient-reported safety, efficacy or misuse of current opioid therapy for chronic pain: A systematic review Pain 154 2013 905 916
6. S.F. Butler, S.H. Budman, G.J. Fanciullo, and R.N. Jamison Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy Clin J Pain 26 2010 770 776
7. S.F. Butler, S.H. Budman, K.C. Fernandez, B. Houle, C. Benoit, N. Katz, and R.N. Jamison Development and validation of the Current Opioid Misuse Measure Pain 130 2007 144 156
8. S.F. Butler, S.H. Budman, K. Fernandez, and R.N. Jamison Validation of a screener and opioid assessment measure for patients with chronic pain Pain 112 2004 65 75
9. S.F. Butler, S.H. Budman, R.J. Goldman, F.L. Newman, K.E. Beckley, D. Trottier, and J.S. Cacciola Initial validation of a computer-administered Addiction Severity Index: The ASI-MV Psychol Addict Behav 15 2001 4 12
10. J.S. Cacciola, A.I. Alterman, A.T. McLellan, Y.T. Lin, and K.G. Lynch Initial evidence for the reliability and validity of a "Lite" version of the Addiction Severity Index Drug Alcohol Depend 87 2007 297 302
11. K.B. Carey, M.P. Carey, and P.S. Chandra Psychometric evaluation of the Alcohol Use Disorders Identification Test and Short Drug Abuse Screening Test with psychiatric patients in India J Clin Psychiatry 64 2003 767 774
12. C.M. Cassidy, N. Schmitz, and A. Malla Validation of the Alcohol Use Disorders Identification Test and the Drug Abuse Screening Test in first episode psychosis Can J Psychiatry 53 2008 26 33
13. C. Chabal, M.K. Erjavec, L. Jacobson, A. Mariano, and E. Chaney Prescription opiate abuse in chronic pain patients: Clinical criteria, incidence, and predictors Clin J Pain 13 1997 150 155
14. R. Chou, G.J. Fanciullo, P.G. Fine, C. Miaskowski, S.D. Passik, and R.K. Portenoy Opioids for chronic noncancer pain: Prediction and identification of aberrant drug-related behaviors: A review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline J Pain 10 2009 131 146
15. K.M. Cocco, and K.B. Carey Psychometric properties of the Drug Abuse Screening Test in psychiatric outpatients Psychol Assess 10 1998 408 414
16. S.D. Comer, J.P. Zacny, R.H. Dworkin, D.C. Turk, G.E. Bigelow, R.W. Foltin, D.R. Jasinski, E.M. Sellers, E.H. Adams, R. Balster, L.B. Burke, I. Cerny, R.D. Colucci, E. Cone, P. Cowan, J.T. Farrar, J.D. Haddox, J.A. Haythornthwaite, S. Hertz, G.W. Jay, C.E. Johanson, R. Junor, N.P. Katz, M. Klein, E.A. Kopecky, D.B. Leiderman, M.P. McDermott, C. O'Brien, A.B. O'Connor, P.P. Palmer, S.N. Raja, B.A. Rappaport, C. Rauschkolb, M.C. Rowbotham, C. Sampaio, B. Setnik, M. Sokolowska, J.W. Stauffer, and S.L. Walsh Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations Pain 153 2012 2315 2324
17. P. Compton, J. Darakjian, and K. Miotto Screening for addiction in patients with chronic pain and "problematic" substance use: Evaluation of a pilot assessment tool J Pain Symptom Manage 16 1998 355 363
18. P.A. Compton, S.M. Wu, B. Schieffer, Q. Pham, and B.D. Naliboff Introduction of a self-report version of the Prescription Drug Use Questionnaire and relationship to medication agreement noncompliance J Pain Symptom Manage 36 2008 383 395
19. S.A. Dunbar, and N.K. Katz Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: Report of 20 cases J Pain Symptom Manage 11 1996 163 171
20. N. El-Bassel, R.F. Schilling, S. Schinke, M. Orlandi, W. Sun, and S. Back Assessing the utility of the Drug Abuse Screening Test in the workplace Res Soc Work Pract 7 1997 99 114
21. European Medicines Agency Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products (July, 2005) Available at: http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/09/WC500003637.pdf Accessed January 21, 2014
22. European Medicines Agency Guideline on the clinical development of medicinal products indented for the treatment of pain (May 30, 2013) Available at: http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2013/05/WC500143769.pdf Accessed January 21, 2014
23. M.D. Finkelman, R.J. Kulilch, D. Zoukhri, N. Smits, and S.F. Butler Shortening the current opioid misuse measure via computer-based testing: A retrospective proof-of-concept study BMC Med Res Methodol 13 2013 126
24. D.A. Fishbain, B. Cole, J. Lewis, H.L. Rosomoff, and R.S. Rosomoff What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review Pain Med 9 2008 444 459
25. D.R. Gavin, H.E. Ross, and H.A. Skinner Diagnostic validity of the Drug Abuse Screening Test in the assessment of DSM-III drug disorders Br J Addict 84 1989 301 307
26. L. Hansen, J. Penko, D. Guzman, D.R. Bangsberg, C. Miaskowski, and M.B. Kushel Aberrant behaviors with prescription opioids and problem drug use history in a community-based cohort of HIV-infected individuals J Pain Symptom Manage 42 2011 893 902
27. R.N. Jamison, E.L. Ross, E. Michna, L.Q. Chen, C. Holcomb, and A.D. Wasan Substance misuse treatment for high-risk chronic pain patients on opioid therapy: A randomized trial Pain 150 2010 390 400
28. S. Jeevanjee, J. Penko, D. Guzman, C. Miaskowski, D.R. Bangsberg, and M.B. Kushel Opioid analgesic misuse is associated with incomplete antiretroviral adherence in a cohort of HIV-infected indigent adults in San Francisco AIDS Behav 18 2014 1352 1358
29. D.N. Juurlink, and I.A. Dhalla Dependence and addiction during chronic opioid therapy J Med Toxicol 8 2012 393 399
30. K.J. Kemper, A. Greteman, E. Bennett, and T.R. Babonis Screening mothers of young children for substance abuse J Dev Behav Pediatr 14 1993 308 312
31. J.S. Knisely, M.J. Wunsch, K.L. Cropsey, and E.D. Campbell Prescription Opioid Misuse Index: A brief questionnaire to assess misuse J Subst Abuse Treat 35 2008 380 386
32. S.A. Maisto, M.P. Carey, K.B. Carey, C.M. Gordon, and J.R. Gleason Use of the AUDIT and the DAST-10 to identify alcohol and drug use disorders among adults with a severe and persistent mental illness Psychol Assess 12 2000 186 192
33. K. Mäkelä Studies of the reliability and validity of the Addiction Severity Index Addiction 99 2004 398 418
34. L. Manchikanti, V. Pampati, K.S. Damron, and C.D. McManus Evaluation of variables in illicit drug use: Does a controlled substance abuse screening tool identify illicit drug use? Pain Physician 7 2004 71 75
35. L. Manchikanti, V. Singh, K.S. Damron, C.D. Beyer, and V. Pampati Screening for controlled substance abuse in an interventional pain management setting: Evaluation of an assessment tool Pain Physician 6 2003 425 433
36. S. Martino, C.M. Grilo, and D.C. Fehon Development of the Drug Abuse Screening Test for Adolescents (DAST-A) Addict Behav 25 2000 57 70
37. B.S. McCann, T.L. Simpson, R. Ries, and P. Roy-Byrne Reliability and validity of screening instruments for drug and alcohol abuse in adults seeking evaluation for attention-deficit/hyperactivity disorder Am J Addict 9 2000 1 9
38. A.T. McLellan, H. Kushner, D. Metzger, R. Peters, I. Smith, G. Grissom, H. Pettinati, and M. Argeriou The fifth edition of the Addiction Severity Index J Subst Abuse Treat 9 1992 199 213
39. A.T. McLellan, L. Luborsky, J. Cacciola, J. Griffith, P. McGahan, and C.P. O'Brien Guide to the Addiction Severity Index: Background, Administration, and Field Testing Results (DHHS publication number [ADM]85-1419) 1985 National Institute on Drug Abuse Rockville, MD
40. A.T. McLellan, L. Luborsky, G.E. Woody, and C.P. O'Brien An improved evaluation instrument for substance abuse patients: The Addiction Severity Index J Nerv Ment Dis 168 1980 26 33
41. E.C. Meltzer, D. Rybin, R. Saitz, J.H. Samet, S.L. Schwartz, S.F. Butler, and J.M. Liebschutz Identifying prescription opioid use disorder in primary care: Diagnostic characteristics of the Current Opioid Misuse Measure (COMM) Pain 152 2011 397 402
42. E. Michna, E.L. Ross, W.L. Hynes, S.S. Nedeljkovic, S. Soumekh, D. Janfaza, D. Palombi, and R.N. Jamison Predicting aberrant drug behavior in patients treated for chronic pain: Importance of abuse history J Pain Symptom Manage 28 2004 250 258
43. T. Møller, and O.M. Linaker Using brief self-reports and clinician scales to screen for substance use disorders in psychotic patients Nord J Psychiatry 64 2010 130 135
44. National Institute on Drug Abuse, U.S. Department of Health and Human Services, National Institute of Health Research report series - prescription drugs: abuse and addiction (NIH publication number 11-4881; revised October 2011). Available at: http://www.drugabuse.gov/sites/default/files/rrprescription.pdf Accessed September 5, 2014
45. C.P. O'Brien, N. Volkow, and T. Li What's in a word? Addiction versus dependence in DSM-V Am J Psychiatry 163 2006 764 765
46. A.B. O'Connor, D.C. Turk, R.H. Dworkin, N.P. Katz, R. Colucci, J.A. Haythornthwaite, M. Klein, C. O'Brien, K. Posner, B.A. Rappaport, G. Reisfield, E.H. Adams, R.L. Balster, G.E. Bigelow, L.B. Burke, S.D. Comer, E. Cone, P. Cowan, R.A. Denisco, J.T. Farrar, R.W. Foltin, J.D. Haddox, S. Hertz, G. Jay, C.E. Johanson, R. Junor, E. Kopecky, D.B. Leiderman, M.P. McDermott, P.P. Palmer, S.N. Raja, C. Rauschkolb, M.C. Rowbotham, C. Sampaio, B. Setnick, S.M. Smith, M. Sokolowska, J.W. Stauffer, S.L. Walsh, and J.P. Zacny Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations Pain 154 2013 2324 2334
47. S.D. Passik, K.L. Kirsh, and D. Casper Addiction-related assessment tools and pain management: Instruments for screening, treatment planning, and monitoring compliance Pain Med 9 suppl 2 2008 S145 S166
48. S.D. Passik, K.L. Kirsh, L. Whitcomb, R.K. Portenoy, N.P. Katz, L. Kleinman, S.L. Dodd, and J.R. Schein A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy Clin Ther 26 2004 552 561
49. J. Porter, and H. Jick Addiction rare in patients treated with narcotics N Engl J Med 302 1980 123
50. R. Saltstone, S. Halliwell, and M.A. Hayslip A multivariate evaluation of the Michigan Alcoholism Screening Test and the Drug Abuse Screening Test in a female offender population Addict Behav 19 1994 455 462
51. M.L. Selzer The Michigan Alcoholism Screening Test: The quest for a new diagnostic instrument Am J Psychiatry 127 1971 1653 1658
52. H.A. Skinner The Drug Abuse Screening Test Addict Behav 7 1982 363 371
53. H.A. Skinner, and A.E. Goldberg Evidence for a drug dependence syndrome among narcotic users Br J Addict 81 1986 479 484
54. S.M. Smith, R.C. Dart, N.P. Katz, F. Paillard, E.H. Adams, S.D. Comer, A. Degroot, R.R. Edwards, J.D. Haddox, J.H. Jaffe, C.M. Jones, H.D. Kleber, E.A. Kopecky, J.D. Markman, I.D. Montoya, C. O'Brien, C.L. Roland, M. Stanton, E.C. Strain, G. Vorsanger, A.D. Wasan, R.D. Weiss, D.C. Turk, and R.H. Dworkin Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations Pain 154 2013 2287 2296
55. D. Staley, and N. El-Guebaly Psychometric properties of the Drug Abuse Screening Test in a psychiatric patient population Addict Behav 15 1990 257 264
56. M.D. Sullivan, M. Von Korff, C. Banta-Green, J.O. Merrill, and K. Saunders Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer pain Pain 149 2010 345 353
57. D.C. Turk, K.S. Swanson, and R.J. Gatchel Predicting opioid misuse by chronic pain patients: A systematic review and literature synthesis Clin J Pain 24 2008 497 508
58. U.S. Food and Drug Administration Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims (December 2009) Available at: http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf Accessed January 21, 2014
59. U.S. Food and Drug Administration Guidance for industry: assessment of abuse potential of drugs (January, 2010) Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM198650.pdf Accessed January 21, 2014
60. U.S. Food and Drug Administration Guidance for industry: qualification process for drug development tools (January, 2014) Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM230597.pdf Accessed January 21, 2014
61. A.D. Wasan, S.F. Butler, S.H. Budman, C. Benoit, K. Fernandez, and R.N. Jamison Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain Clin J Pain 23 2007 307 315
62. A.D. Wasan, S.F. Butler, S.H. Budman, K. Fernandez, R.D. Weiss, S.F. Greenfield, and R.N. Jamison Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients? Clin J Pain 25 2009 193 198
63. S.M. Wu, P. Compton, R. Bolus, B. Schieffer, Q. Pham, A. Baria, W. Van Vort, F. Davis, P. Shekelle, and B.D. Naliboff The Addiction Behaviors Checklist: Validation of a new clinician-based measure of inappropriate opioid use in chronic pain J Pain Symptom Manage 32 2006 342 351